Sponsor:
Medical College of Wisconsin
Code:
NCT07117136
Conditions
B-Cell Acute Lymphoblastic Leukaemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Brief summary:
Conditions
B-Cell Acute Lymphoblastic Leukaemia
Study ID
NCT07117136
Start date
Aug 28, 2025
Status verified date
Nov, 2025
Completion date
May 14, 2029
Anticipated
Primary completion date
May 14, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
200 participants
Anticipated
Arms
Patients who received Blinatumomab Therapy
Patients who did not receive Blinatumomab Therapy
Primary outcome measure
Central contacts
Locations
Mayo Clinic Cancer Center
Recruiting
Jacksonville, Florida, United States, 32224
Contacts
Principal Investigator:
Talha Badar, MD
University of Pennsylvania
Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contacts
Principal Investigator:
Selina Luger, MD
Medical College of Wisconsin
Recruiting
Milwaukee, Wisconsin, United States, 53226
Contacts
Principal Investigator:
Ehab Atallah, MD
Sponsor
Medical College of Wisconsin
Last update posted
Jul 31, 2026
Last verified
Nov, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Medical College of Wisconsin on 2026-07-31.